Filtered By:
Condition: Atrial Fibrillation
Management: National Institute for Health and Clinical Excelle

This page shows you your search results in order of date.

Order by Relevance | Date

Total 31 results found since Jan 2013.

Mr. M
Dr. Migliore I step off the subway, up the elevator, and up several flights of stairs. There’s a homeless man there who always uses the last stair of the lower staircase as a tray for his food. And by tray, I mean he sets his half-eaten rice burrito directly onto the step and picks around at it while I imagine the guacamole is mixing with Hep B and C. diff and MRSA. He looks up at me, I promise myself for the 100th time I’m going to start carrying cash or Kind bars or something; I give him my best sheepish face, and emerge at street level. I walk toward my hospital and pass a gentleman who sits on a ledge next to the ...
Source: The Hospitalist - December 1, 2022 Category: Hospital Management Authors: Lisa Casinger Tags: Essay Source Type: research

CO33 Methodological Challenges and Considerations for Decision Makers When Assessing within-Class Comparative Effectiveness and Cost-Effectiveness: The Case of Non-Vitamin K Antagonist Oral Anticoagulants
The United Kingdom National Institute of Health Care Excellence (NICE) published a draft clinical guideline for consultation on anticoagulation therapy for stroke prevention in individuals with atrial fibrillation in September 2020 that addressed which non-vitamin K antagonist oral anticoagulant (NOAC) therapy (apixaban, dabigatran, rivaroxaban, edoxaban) is most clinically and cost-effective. We aimed to elucidate methodological considerations and challenges involved in evaluating the comparative effectiveness and cost-effectiveness of within-class treatments for the  purpose of decision making by a reimbursement authority.
Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: A Briggs, A Howarth, S Davies, J Schneider, G Spentzouris, F Mughal, A Fuat, M Fay Source Type: research

Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations
Eur J Intern Med. 2022 May 4:S0953-6205(22)00166-2. doi: 10.1016/j.ejim.2022.04.023. Online ahead of print.ABSTRACTClinical practice in atrial fibrillation (AF) patient management is constantly evolving. In the past 3 years, various new AF guidelines or focused updates have been published, given this rapidly evolving field. In 2019, the American College of Cardiology/American Heart Association published a focused update of the 2014 guidelines. In 2020, both the European Society of Cardiology and the Canadian Cardiovascular Society released their new guidelines. Finally, the most recent guidelines were those published in 20...
Source: European Journal of Internal Medicine - May 7, 2022 Category: Internal Medicine Authors: Jacopo Francesco Imberti Davide Antonio Mei Marco Vitolo Niccol ò Bonini Marco Proietti Tatjana Potpara Gregory Y H Lip Giuseppe Boriani Source Type: research

IJERPH, Vol. 19, Pages 4467: A Nurse-Led Integrated Chronic Care E-Enhanced Atrial Fibrillation (NICE-AF) Clinic in the Community: A Preliminary Evaluation
This study aims to provide a preliminary evaluation of the effectiveness of a Nurse-led Integrated Chronic care E-enhanced Atrial Fibrillation (NICE-AF) clinic in the community. The NICE-AF clinic was led by an advanced practice nurse (APN) who collaborated with a family physician. The clinic embodied integrated care and shifted from hospital-based, physician-centric care. Regular patient education, supplemented by a specially curated webpage, fast-tracked appointments for hospital-based specialised investigations, and teleconsultation with a hospital-based cardiologist were the highlights of the clinic. Forty-three partic...
Source: International Journal of Environmental Research and Public Health - April 7, 2022 Category: Environmental Health Authors: Brigitte Fong Yeong Woo Wilson Wai San Tam Taiju Rangpa Wei Fong Liau Jennifer Nathania Toon Wei Lim Tags: Article Source Type: research

NICE recommends implantable monitor to identify atrial fibrillation after stroke
Source: BMJ News - January 14, 2020 Category: General Medicine Source Type: research

‘We’re Not As Healthy As We Should Be.’ Fitbit CEO James Park Discusses New AFib Detection Partnership With Bristol-Myers Squibb-Pfizer
“We’re not as healthy as we should be.” That’s what Fitbit CEO and co-founder James Park said at Thursday’s TIME 100 Health Summit, where MSNBC anchor Stephanie Ruhle interviewed him about the company’s future in the health care space, the impact of wearables and just how active Fitbit’s 30 million active users really are. Ruhle talked with Park about Fitbit’s position as one of the first major wearables company to have gone public, one that led the charge in terms of mass market adoption but has lost ground to competitors offering more advanced wearable devices, as well as ...
Source: TIME: Health - October 17, 2019 Category: Consumer Health News Authors: Patrick Lucas Austin Tags: Uncategorized fitness HealthSummit19 technology Source Type: news

108appropriate anticoagulation in older adults with atrial fibrillation
Introduction: Anticoagulation is recommended to prevent stroke in atrial fibrillation. NICE Guidelines state anticoagulation should be offered to all patients with a CHADVASC of 2 and above. The ESC (European Society of Cardiology) guidelines advise falls and advanced dementia should not prevent patients from receiving anticoagulation. Furthermore, advanced age (above 75 or 80 years old) should not mean anticoagulation is withheld, especially as the risk of ischaemic stroke increases with age and comorbidities.
Source: Age and Ageing - March 27, 2018 Category: Geriatrics Source Type: research

103 How is our local AF management? The management of atrial fibrillation (af) in coventry and rugby clinical commissioning group (ccg), england compared to national data and nice (national institute for clinical excellence) 2014
Background: AF is the most common cardiac arrhythmia affecting 2% in the UK.AF carriers 5 fold risk of stroke, with increased stroke mortality, morbidity& longer hospital stay.CHADSVAs guides anti-coagulation ( ≥1 anti-coagulate)Risk factor modification reduces AF reoccurrenceNurse led clinics reduce AF related stroke risk, improve AF management, risk factor reduction whilst providing safe anticoagulation.
Source: Europace - October 5, 2017 Category: Cardiology Source Type: research

115 Anticoagulation in atrial fibrillation – a single-centre audit on patient education, stroke and bleeding risk assessments and use of direct oral anticoagulants (DOACs)
Objective: To assess adherence to the National Institute of Health and Care Excellence (NICE) guidelines on management of atrial fibrillation in adults, specifically the provision of a personalised package of care and information to patients, and stroke and bleeding risk assessments. To assess the frequency of use of DOACs as the anticoagulant of choice.
Source: Europace - October 5, 2017 Category: Cardiology Source Type: research

124 GP-led anticoagulation counselling for non-valvular atrial fibrillation (AF) in the community is neither comprehensive nor accurate: Results from a service improvement project.
Background: Stroke risk in NVAF can be reduced significantly by anticoagulation with either warfarin or the non- vitamin K antagonist (NOACs). NICE recommendations state that NOACs are as efficacious but also associated with significantly less intracranial bleeding compared to Warfarin and in this sense are safer than warfarin. Additionally NOACs do not require regular monitoring of their anticoagulant effects and therefore offer convenience to the patient. However they are not as tried and tested as warfarin and at the time of our study, did not have an available agent to reverse their effects in the event of a bleeding c...
Source: Europace - October 5, 2017 Category: Cardiology Source Type: research

A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation: 3-Year Financial Projections For Three UK Regions
Atrial Fibrillation (AF) is a common and treatable risk factor for ischaemic stroke and vascular dementia with rising incidence. Oral anticoagulation (OAC) therapy is a well-evidenced way to prevent AF-related strokes, as supported by NICE Clinical Guidelines (CG180, 2014).
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: A Orlowski, T Jamieson, J Belsey, R Slater, J Macdonald Source Type: research

Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation
The objectives were to Identify respiratory patients with non-valvular AF. In those already anti-coagulated, we aimed identify which anticoagulant was in use. In appropriate patients not previously anticoagulated and new paroxysmal AF patients, we determined whether the patient was anti-coagulated by the respiratory firm.Data was collected directly from patient casenotes on two respiratory wards in November 2015 and February 2016. There were 24 patients with included in the first round of data collection, and 26 in the second.Anticoagulation coverage of patients with non-valvular AF was intitally poor (20%). Furthermore, d...
Source: European Respiratory Journal - November 7, 2016 Category: Respiratory Medicine Authors: Pugh, A., Campbell, C. Tags: 1.13 Clinical Problems - Other Source Type: research

NICE aims to prevent 8,000 strokes
NICE is calling for GPs and CCGs to focus on preventing 8,000 strokes a year. New NICE indicators will help GPs and CCGs improve the identification and management of atrial fibrillation (AF) – a common heart condition that causes an irregular heartbeat and increases the risk of stroke.
Source: NHS Networks - August 2, 2016 Category: UK Health Source Type: news

NICE wants GPs to prevent 8,000 strokes a year
New guidance could help identify atrial fibrillation Related items fromOnMedica Atrial fibrillation poses greater risk for women than men Never too old to benefit from CVD prevention Stroke can often be avoided, claims study Stroke rates rocket in younger men and women Dementia and stroke funding remains too low, say experts
Source: OnMedica Latest News - July 31, 2016 Category: UK Health Source Type: news

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
This report ends with a list of priorities for research in AF patients.
Source: Europace - February 3, 2016 Category: Cardiology Authors: Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., Calvert, M., Christoffels, V., Crijns, H., Dobrev, D., Ellinor, P., Fabritz, L., Fetsch, T., Freedman, S. B., Tags: EHRA CONSENSUS STATEMENT Source Type: research